+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

P

Actively Recruiting

Researchers are evaluating how well adults with new-onset generalized myasthenia gravis gMG respond to treatment with efgartigimod PH20 SC. This study focuses on adults who have had generalized disease signs or symptoms for less than one year and aims to assess clinical outcomes during a phase 4, open-label, single-group trial. Participants will receive subcutaneous injections of efgartigimod PH20 SC during a treatment period lasting 51 weeks. The study follows each participant for approximately 58 weeks to monitor their response to the treatment and any changes in their condition over time. During the study, participants will be regularly evaluated using measures like the proportion who achieve minimal symptom expression MSE within the first 16 weeks, changes in MG-ADL and MG-QOL-15r scores over time, and use of systemic corticosteroids as add-on therapy. Researchers will also monitor the incidence of adverse events throughout the study period to assess safety and tolerability.

Age: 18Years +All GendersPhase 4
18 locations
C

Actively Recruiting

Healthy Volunteer

Researchers are conducting a study to collect and store biological samples from children and adults diagnosed with common childhood cancers or adult cancers that share characteristics with pediatric malignancies. The study aims to create a tissue repository and perform comprehensive molecular, genomic, proteomic, metabolomic, and other advanced profiling techniques to better understand cancer biology and support related biological research. Participants may provide extra blood, serum, tissue, urine, or tumor samples during routine medical care or approved research procedures, with no additional invasive procedures solely for sample collection. The study also involves collecting previously obtained specimens and includes participants with a range of cancer diagnoses, suspected cancer susceptibility syndromes, their biological relatives, and healthy volunteers undergoing routine care or surgery. During the study, participants will undergo sample collection at times aligned with their routine care or research visits. Researchers will analyze these specimens using various advanced techniques, including DNA, RNA, and protein extraction, immune and stromal profiling, and cell population analyses. The study will also explore attitudes and beliefs about genetic testing related to pediatric cancer. The primary outcome is ongoing tissue analysis, with an expected enrollment of 100 to 150 patients annually.

Age: 4Weeks +All Genders
5 locations